Stella Ko, PharmD, MS
Stella is a second-year postdoctoral fellow at the CHOICE Institute/Genentech. After completing her first year of the fellowship at the CHOICE Institute and earning her master’s degree in health economics and outcomes research (HEOR), she is currently working at Evidence for Access, Genentech, supporting health economist leads in developing evidence strategies and tactics for immunology/respiratory and ophthalmology portfolios.
During her time at Genentech, she has been involved in numerous HEOR studies, including economic modeling and analyses, patient-reported outcomes research (discrete choice experiment), and real-world evidence generation in preparation of product launch (Xolair (omalizumab) in food allergy).
Before the fellowship, she gained relevant experience at the University of North Carolina (UNC) Health System and AESARA. During her time at UNC Health System, she created a drug monograph for consideration in the Integrated Delivery Network formulary. Additionally, she was a health economics and outcomes research/Market Access Intern at AESARA, organizing an AMCP dossier for a new drug to be considered on the payer’s formulary.
After the fellowship, she aspires to pursue a career in the pharmaceutical industry, focusing on HEOR strategy to play a crucial role in improving formulary access by providing evidence-based insights into the clinical, economic, and humanistic outcomes of healthcare interventions.
Email: stellako@uw.edu
LinkedIn: https://www.linkedin.com/in/stellayeko/